{"title":"[风疹控制和免疫战略的进展]。","authors":"Jing Ma, Li-Xin Hao, Hui-Ming Luo","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Rubella is one of the global public health problems, and the main harm is CRS which derives from pregnant women that infected rubella virus in the first pregnant periods. CRS could cause great economic burden to society. In order to decrease the incidence of Rubella and CRS, China has integrated MMR into Expanded Program on Immunization (EPI) in 2007. This article will provide some ideas on Rubella vaccine into EPI. The paper will review the rubella vaccine immunigation Strategy both at home and abroad.</p>","PeriodicalId":56402,"journal":{"name":"中国疫苗和免疫","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2010-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Progress on rubella control and immunization strategies].\",\"authors\":\"Jing Ma, Li-Xin Hao, Hui-Ming Luo\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Rubella is one of the global public health problems, and the main harm is CRS which derives from pregnant women that infected rubella virus in the first pregnant periods. CRS could cause great economic burden to society. In order to decrease the incidence of Rubella and CRS, China has integrated MMR into Expanded Program on Immunization (EPI) in 2007. This article will provide some ideas on Rubella vaccine into EPI. The paper will review the rubella vaccine immunigation Strategy both at home and abroad.</p>\",\"PeriodicalId\":56402,\"journal\":{\"name\":\"中国疫苗和免疫\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2010-02-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"中国疫苗和免疫\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"中国疫苗和免疫","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
[Progress on rubella control and immunization strategies].
Rubella is one of the global public health problems, and the main harm is CRS which derives from pregnant women that infected rubella virus in the first pregnant periods. CRS could cause great economic burden to society. In order to decrease the incidence of Rubella and CRS, China has integrated MMR into Expanded Program on Immunization (EPI) in 2007. This article will provide some ideas on Rubella vaccine into EPI. The paper will review the rubella vaccine immunigation Strategy both at home and abroad.